Cargando…
Variations of BRAF mutant allele percentage in melanomas
BACKGROUND: BRAF mutations are present in 40 % of human skin melanomas. Mutated tumors with an increased percentage of BRAF mutant alleles (BRAF-M%) may have a better response to RAF/MEK inhibitors. We evaluated the BRAF-M% in melanomas, and the genetic causes of its variation. METHODS: BRAF-M% was...
Autores principales: | Hélias-Rodzewicz, Zofia, Funck-Brentano, Elisa, Baudoux, Laure, Jung, Chan Kwon, Zimmermann, Ute, Marin, Cristi, Clerici, Thierry, Le Gall, Catherine, Peschaud, Frédérique, Taly, Valérie, Saiag, Philippe, Emile, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491198/ https://www.ncbi.nlm.nih.gov/pubmed/26141748 http://dx.doi.org/10.1186/s12885-015-1515-3 |
Ejemplares similares
-
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2017) -
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
por: Emile, Jean-François, et al.
Publicado: (2013) -
Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors
por: Lourenço, Nelson, et al.
Publicado: (2014) -
New somatic BRAF splicing mutation in Langerhans cell histiocytosis
por: Héritier, Sébastien, et al.
Publicado: (2017) -
Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression
por: Giroux Leprieur, Etienne, et al.
Publicado: (2020)